SunTrust Robinson Humphrey Downgrades Bristol-Myers Squibb Co. (BMY) to Neutral
Tweet
Share
E-mail
Get Alerts BMY Hot Sheet
Price: $57.42 +2.88%
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 18
Rating Summary:
11 Buy, 23 Hold, 4 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 4 | Down: 5 | New: 18
Join SI Premium – FREE
SunTrust Robinson Humphrey downgraded Bristol-Myers Squibb Co. (NYSE: BMY) from Buy to Neutral with a price target of $68.00 (from $86.00).
For an analyst ratings summary and ratings history on Bristol-Myers Squibb Co. click here. For more ratings news on Bristol-Myers Squibb Co. click here.
Shares of Bristol-Myers Squibb Co. closed at $75.32 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Roblox falls 4% in pre-market as Wells Fargo bookings caution reasserts
- Watts Waters (WTS) PT Raised at TD Cowen; 'Shares May Be Ahead Of Themselves, But The Idea Makes Sense'
- ICICI Securities Downgrades HCL Technologies (HCLT:IN) to Reduce (4)
Create E-mail Alert Related Categories
Analyst PT Change, DowngradesRelated Entities
SunTrust Robinson HumphreySign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
